Document is current
Any future updates will be listed below
-
Authors
Lin, Mingqian
Estrada-Merly, Noel
Eapen, Mary
Zamora, Anthony E. http://orcid.org/0000-0001-5712-5339
Pezzin, Liliana E.
Winn, Aaron N.
Philip, Joyce
Schinke, Carolina
Drobyski, William R. http://orcid.org/0000-0001-7121-6499
Anderson, Larry D. Jr. http://orcid.org/0000-0002-6531-9595
D’Souza, Anita http://orcid.org/0000-0002-1092-5643
-
Funding
Funding for this research was provided by:
Medical College of Wisconsin (CHDS)
- License Information
-
More Information
Article History
Received: 14 August 2023
Revised: 17 August 2023
Accepted: 30 August 2023
First Online: 6 September 2023
Competing interests
: ML, NE, ME, LEP, ANW, JP, WD report no conflicts of interest relevant to this work. AEZ reports research support from PhenomeX not related to the data presented in the current study. CS reports Consulting/Advisory Board activity with Janssen and Pfizer. LA reports Consulting/Advisory Board activity with: Janssen, Celgene, BMS, Amgen, GSK, AbbVie, Beigene, Cellectar, Sanofi, Prothena; AD reports institutional research funding from Abbvie, Caelum, Janssen, Novartis, Prothena, Sanofi, Sorrento, TeneoBio, consulting/advisory board activity with BMS, Janssen, Pfizer, Prothena.
